Changes in the composition of intestinal fungi and their role in mice with dextran sulfate sodium-induced colitis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Qiu, Xinyun ^a   Zhang, Feng ^a   Yang, Xi ^b   Wu, Na ^a   Jiang, Weiwei ^a   Li, Xia ^a   Li, Xiaoxue ^a   Liu, Yulan ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN; BETA-1,3-D-GLUCAN; CYTOKINE; DEXTRAN SULFATE; FLUCONAZOLE; OCCLUDIN; PROTEIN ZO1; RNA 16S; RNA 18S; TJP1 PROTEIN, MOUSE;

ACUTE DISEASE; ANIMAL; BLOOD; C57BL MOUSE; COLITIS; COLON; DISCRIMINANT ANALYSIS; DISEASE MODEL; DRUG EFFECTS; FUNGUS; GENETICS; INFLAMMATION; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; LEAST SQUARE ANALYSIS; LYMPH NODE; METABOLISM; MICROBIOLOGY; MOUSE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN;

ACUTE DISEASE; ANIMALS; BETA-GLUCANS; COLITIS; COLON; CYTOKINES; DEXTRAN SULFATE; DISCRIMINANT ANALYSIS; DISEASE MODELS, ANIMAL; FLUCONAZOLE; FUNGI; INFLAMMATION; INTESTINAL MUCOSA; LEAST-SQUARES ANALYSIS; LYMPH NODES; MICE; MICE, INBRED C57BL; OCCLUDIN; REAL-TIME POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; RNA, RIBOSOMAL, 18S; SPLEEN; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84934882135     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10416     Document Type: Article

References (43)

1. Manichanh, C., Borruel, N., Casellas, F. & Guarner, F. The gut microbiota in IBD. Nat. Rev. Gastroenterol. Hepatol. 9, 599-608 (2012).
2. Yu, C. G. & Huang, Q. Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease. J. Dig. Dis. 14, 513-517 (2013).
3. Iliev, I. D. et al. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Sci. Signal. 336, 1314 (2012).
4. Koh, A. Y. Gastrointestinal Colonization of Fungi. Curr. Fungal Infect Rep. 7, 144-151 (2013).
5. Peleg, A. Y., Hogan, D. A. & Mylonakis, E. Medically important bacterial-fungal interactions. Nat. Rev. Microbiol. 8, 340-349 (2010).
6. Schulze, J. & Sonnenborn, U. Yeasts in the gut: from commensals to infectious agents. Dtsch. Arztebl. Int. 106, 837-842 (2009).
7. Zwolinska-Wcislo, M. et al. Effect of Candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of colitis ulcerosa. J. Physiol. Pharmacol. 60, 107-118 (2009).
8. Chen, W. et al. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS One 7, e39743 (2012).
9. Gevers, D. et al. The Treatment-Naive Microbiome in New-Onset Crohn's Disease. Cell host & microbe. 15, 382-392 (2014).
10. Huffnagle, G. B. & Noverr, M. C. The emerging world of the fungal microbiome. Trends Microbiol. 21, 334-341 (2013).
11. Iliev, I. D. & Underhill, D. M. Striking a balance: fungal commensalism versus pathogenesis. Curr. Opin. Microbiol 16, 366-373 (2013).
12. Ott, S. J. et al. Fungi and inflammatory bowel diseases: Alterations of composition and diversity. Scand. J. Gastroenterol. 43, 831-841 (2008).
13. Underhill, D. M. & Iliev, I. D. The mycobiota: interactions between commensal fungi and the host immune system. Nat. Rev. Immunol. 14, 405-416 (2014).
14. Standaert-Vitse, A. et al. Candida albicans colonization and ASCA in familial Crohn's disease. Am. J. Gastroenterol. 104, 1745-1753 (2009).
15. Randhawa, P. K. et al. A review on chemical-induced inflammatory bowel disease models in rodents. Korean J. Physiol. Pharmacol. 18, 279-288 (2014).
16. Heinsbroek, S. E. et al. Genetic deletion of dectin-1 does not affect the course of murine experimental colitis. BMC Gastroenterol. 12, 33 (2012).
17. Dollive, S. et al. Fungi of the murine gut: episodic variation and proliferation during antibiotic treatment. PLoS One 8, e71806 (2013).
18. Wu, N. et al. Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb. Ecol. 66, 462-470 (2013).
19. Mukherjee, P. K. et al. Mycobiota in gastrointestinal diseases. Nat. Rev. Gastroenterol. Hepatol. 12, 77-87 (2014).
20. Mukhopadhya, I. et al. The fungal microbiota of de-novo paediatric inflammatory bowel disease. Microbes. Infect. 14, S1286-4579 (2014).
21. Trojanowska, D. et al. The role of Candida in inflammatory bowel disease. Estimation of transmission of C. albicans fungi in gastrointestinal tract based on genetic affinity between strains. Med. Sci. Monit. 16, Cr451-457 (2010).
22. Roberts, C. L. et al. Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers. Gut. 59, 1331-1339 (2010).
23. O'Brien, C. L., Pavli, P., Gordon, D. M. & Allison, G. E. Detection of bacterial DNA in lymph nodes of Crohn's disease patients using high throughput sequencing. Gut 63, 1596-1606 (2014).
24. Peyrin-Biroulet, L. et al. Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease. Gut. 61, 78-85 (2012).
25. Fiorucci, S. et al. Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis. Digestion 66, 246-256 (2002).
26. Brun, P. et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am. J. Physiol. Gastrointest. Liver. Physiol. 292, G518-G525 (2007).
27. Joly Condette, C. et al. Increased gut permeability and bacterial translocation after chronic chlorpyrifos exposure in rats. PLoS One 9, e102217 (2014).
28. Alaish, S. M. et al. Gut microbiota, tight junction protein expression, intestinal resistance, bacterial translocation and mortality following cholestasis depend on the genetic background of the host. Gut. Microbes. 4, 292-305 (2013).
29. Chiba, M. et al. Elevated plasma (1-> 3)-beta-D-glucan, a fungal cell wall constituent, in a subgroup of Crohn disease. Scand. J. Gastroenterol. 36, 447-448 (2001).
30. He, S. et al. A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-beta-d-glucan for invasive fungal infection: Focus on cutoff levels. J. Microbiol. Immunol. Infect. 14, S1684-1182 (2014).
31. Matsuda, H. et al. Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis. J. Gastroenterol. Hepatol. 15, 61-68 (2000).
32. Pineton de Chambrun, G. P., Torres, J., Darfeuille-Michaud, A. & Colombel, J. F. The role of anti(myco)bacterial interventions in the management of IBD: is there evidence at all? Dig Dis 30, 358-367 (2012).
33. Morgan, X. C. et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 13, R79 (2012).
34. Li, Y. et al. Phylogenetic and functional gene structure shifts of the oral microbiomes in periodontitis patients. ISME J 8, 1879-1891 (2014).
35. Baxter, N. T., Zackular, J. P., Chen, G. Y. & Schloss, P. D. Structure of the gut microbiome following colonization with human feces determines colonic tumor burden. Microbiome 2, 20 (2014).
36. Berry, D. & Reinisch, W. Intestinal microbiota: a source of novel biomarkers in inflammatory bowel diseases? Best Pract Res Clin Gastroenterol 27, 47-58 (2013).
37. Hamaker, B. R. & Tuncil, Y. E. A Perspective on the Complexity of Dietary Fiber Structures and Their Potential Effect on the Gut Microbiota. J Mol Biol 23, 3838-3850 (2014).
38. Garrett, W. S. et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131, 33-45 (2007).
39. Batra, A. et al. Mesenteric fat-control site for bacterial translocation in colitis? Mucosal immunol 5, 580-591 (2012).
40. Shannon, C. E. The mathematical theory of communication. 1963. MD Comput 14, 306-317 (1997).
41. Sokol, H. et al. Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice. Gastroenterology 145, 591-601 (2013).
42. Qiu, X. et al. Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBSinduced colitis. J Crohns Colitis 7, e558-568 (2013).
43. Dieleman, L. A. et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 114, 385-391 (1998).